INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 99 filers reported holding INTERSECT ENT INC in Q2 2016. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $643,000 | -89.6% | 37,815 | -86.0% | 0.23% | -90.5% |
| Q2 2019 | $6,158,000 | +192.1% | 270,561 | +312.7% | 2.43% | +191.5% |
| Q1 2019 | $2,108,000 | +824.6% | 65,557 | +446.3% | 0.83% | +1025.7% |
| Q1 2016 | $228,000 | -74.7% | 12,000 | -70.0% | 0.07% | -75.4% |
| Q4 2015 | $900,000 | +83.3% | 40,000 | +133.4% | 0.30% | +107.6% |
| Q2 2015 | $491,000 | -69.8% | 17,135 | -72.8% | 0.14% | -73.0% |
| Q1 2015 | $1,627,000 | – | 63,000 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |